Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical (300937.SZ) announced a pre-reduction, with an expected annual net profit of 14.5 to 19.5 million yuan, a year-on-year decrease of 67.24% to 75.64%.

Sichuan Hezong Medicine Easy-To-Buy Pharmaceutical (300937.SZ) disclosed its performance forecast for 2024, with the company expecting a net profit attributable to shareholders of the listed company of 14.5 million to 19.5 million yuan, a year-on-year decrease of 67.24% to 75.64%; after deducting non-recurring gains and losses, the net profit is expected to be 8.75 million to 12.75 million yuan, a year-on-year decrease of 76.40% to 83.81%.